Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

ABT MDT SYK ISRG Software Chemicals Data Storage Soft Drinks 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Collecting data for ABT

Abbott quote and profile

 
 Companies |  Insiders  | Dashboard  
     
36.21
  
STOCK
(1.30)  Macroaxis: -3.47 Down   3.47%  
Year To Date
29.538.77
Last 1 Month(s)
36.338.56
Trading Day 
36.2137.27
June 19 2013 

Diversification Suggestion

Use Abbott to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals
Analyze Abbott Laboratories Trend or Check current 30 days Abbott correlation with market (S&P 500)
1 Month Beta 1.32  
Highest Price:  
Lowest Price:  
38.56  
36.3  
May 28 2013 
June 05 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Abbott will likely underperform.
Abbott Laboratories Large BetaAbbott Laboratories Beta Legend
ABT United States NYSE
Abbott Laboratories
Healthcare
Medical Appliances and Equipment
Benchmark S&P 500
http://www.abbott.com
Contact Number: 847. 937. 6100
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation55.75 B
Shares Outstanding1.56 B
Number of Shares Shorted12.43 M
Revenue39.97 B
 United States Russel   1.35 % Macroaxis: change 1.35 Moved Down  
 
 United States SP 500   1.39 % Macroaxis: change 1.39 Moved Down  
 
 United States NYSE   1.53 % Macroaxis: change 1.53 Moved Down  
 
 thisRed ABT ABT agains markets  3.47 % Macroaxis: change 3.47 Moved Down  
 
Compare to Competition Alpha & Beta   Get Advice

Abbott Leadership

Miles White Chairman, CEO and Chairman of Executive Committee
Paul Magill Senior Vice President Chief Marketing Officer
Carlos Alban Senior Vice President - Proprietary Pharmaceutical Products, Global Commercial Operations
Brian Yoor Vice President - Investor Relations

Abbott Price and Market Media

The median price of Abbott for the period between Mon, May 20, 2013 and Wed, Jun 19, 2013 is 37.48 with a coefficient of variation of 1.55. The daily time series for the period is distributed with a sample standard deviation of 0.58, arithmetic mean of 37.25, and mean deviation of 0.5. The Stock received substential amount of media coverage during this period.
Abbott         SP 500
Price Growth (%)
 
Change Benchmark  Embed  Export  Timeline
1
UPDATE Goldman Sachs Upgrades Abbott Laboratories Growth Is ...05/21/2013Macroaxis: News
2
How Will Q1 Results Impact Abbott Laboratorie Stock05/24/2013Macroaxis: News
3
Abbott Laboratories Irish subsidiary paid no tax on 1.8 bill...05/28/2013Macroaxis: News
4
Abbott Laboratorie Management Presents at Deutsche Bank 38th...05/30/2013Macroaxis: Seeking Alpha News
5
ABBOTT LABORATORIES Two RealWorld European Studies of Abbott...06/05/2013Macroaxis: News
6
Jefferies Raises Price Target on Abbott Labs Sees 26.7 Upsid...06/07/2013Macroaxis: News
7
ABBOTT LABORATORIES Abbott Initiates Randomized Clinical Tri...06/12/2013Macroaxis: News
8
Abbott Loves Abbott Laboratories Stock06/18/2013Macroaxis: Fool News

Abbott Summary

Abbott Laboratories [ABT] is traded on New York Stock Exchange in USA. It is located in Abbott Park, IL and employs 91,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 57.93 B. Abbott Laboratories runs under Healthcare sector within Medical Appliances and Equipment industry. This company has 1.56 B outstanding shares of which 12.43 M shares are presently shorted by investors with about 1.7 days to cover shorted positions.
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care solutions worldwide. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
12 %
 
Follow Abbott with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Abbott to your reader
 

Abbott Research Report

Abbott vs. Medtronic

Correlation analysis and fundamentals comparison between Abbott Laboratories and Medtronic Inc

Abbott Executives

Thomas Freyman CFO and Executive VP of Fin.

Abbott Directors

Nancy McKinstry Independent Director
Edward Liddy Independent Director
William Osborn Independent Director, MBA
Sally Blount Independent Director
Samuel Scott Independent Director

Abbott Management

John Landgraf Executive VP of Nutritional Products
Richard Ashley Executive VP of Corporate Devel.
Hubert Allen Executive VP, General Counsel and Secretary

Abbott Fundamentals

Price to Earnings To Growth vs Net Income
Return On Asset vs Profit Margin
Price to Earnings To Growth vs EBITDA
Number of Employees vs Profit Margin

Abbott vs Competition

Abbott vs. Medtronic Inc
Abbott vs. Smith Nephew plc

Abbott June 19 2013 Opportunity Range

Downside Deviation1.47
Information Ratio0.0066
Maximum Drawdown4.8
Value At Risk(2.18)
Potential Upside2.12

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium